OrthoPediatrics Corp. (NASDAQ:KIDS) Short Interest Update

OrthoPediatrics Corp. (NASDAQ:KIDS - Get Free Report) was the recipient of a significant increase in short interest in the month of December. As of December 31st, there was short interest totalling 912,100 shares, an increase of 10.9% from the December 15th total of 822,400 shares. Approximately 5.6% of the company's shares are short sold. Based on an average daily trading volume, of 211,000 shares, the days-to-cover ratio is presently 4.3 days.

OrthoPediatrics Stock Performance

Shares of NASDAQ KIDS traded up $0.63 during mid-day trading on Monday, reaching $27.16. 481,435 shares of the company's stock were exchanged, compared to its average volume of 238,061. The company has a debt-to-equity ratio of 0.19, a current ratio of 7.17 and a quick ratio of 3.68. The firm has a market capitalization of $657.82 million, a price-to-earnings ratio of -22.08 and a beta of 1.14. OrthoPediatrics has a 52 week low of $21.02 and a 52 week high of $35.99. The firm has a 50-day moving average price of $23.98 and a two-hundred day moving average price of $27.33.

Wall Street Analysts Forecast Growth

KIDS has been the subject of several research analyst reports. Truist Financial decreased their price target on shares of OrthoPediatrics from $28.00 to $25.00 and set a "hold" rating for the company in a research note on Wednesday, December 18th. Needham & Company LLC reissued a "buy" rating and issued a $42.00 price target on shares of OrthoPediatrics in a research report on Tuesday, January 14th.

Hedge Funds Weigh In On OrthoPediatrics

Several institutional investors have recently bought and sold shares of the company. Harbor Capital Advisors Inc. raised its holdings in OrthoPediatrics by 1.9% during the 4th quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company's stock valued at $5,832,000 after acquiring an additional 4,728 shares during the period. Barclays PLC raised its position in shares of OrthoPediatrics by 319.3% during the 3rd quarter. Barclays PLC now owns 25,298 shares of the company's stock valued at $686,000 after buying an additional 19,264 shares in the last quarter. Geode Capital Management LLC raised its position in OrthoPediatrics by 2.1% during the third quarter. Geode Capital Management LLC now owns 391,492 shares of the company's stock valued at $10,615,000 after purchasing an additional 7,972 shares in the last quarter. Wellington Management Group LLP lifted its position in OrthoPediatrics by 16.2% in the 3rd quarter. Wellington Management Group LLP now owns 883,221 shares of the company's stock worth $23,944,000 after buying an additional 122,846 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of OrthoPediatrics by 1.0% in the 3rd quarter. State Street Corp now owns 417,898 shares of the company's stock worth $11,329,000 after acquiring an additional 4,236 shares during the last quarter. Hedge funds and other institutional investors own 69.05% of the company's stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.